Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. - Wikidata - awgldk - TriplyDB

Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.

Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.

http://www.wikidata.org/entity/Q42203239

about

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector The structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasion Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6 Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking Structure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9 Structural Insights into Adeno-Associated Virus Serotype 5 Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20 Structure of AAV-DJ, a Retargeted Gene Therapy Vector: Cryo-Electron Microscopy at 4.5 Å Resolution The structure of AAVrh32.33, a novel gene delivery vector E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution Structure of neurotropic adeno-associated virus AAVrh.8.Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer Engineering antibody-like inhibitors to prevent and treat HIV-1 infection.Comparative analysis of adeno-associated virus capsid stability and dynamics Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.Molecular engineering of viral gene delivery vehicles DNA shuffling of adeno-associated virus yields functionally diverse viral progeny Molecular evolution of adeno-associated virus for enhanced glial gene delivery.Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.The 2.8 Å Electron Microscopy Structure of Adeno-Associated Virus-DJ Bound by a Heparinoid Pentasaccharide.Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION.Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity.Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD.Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter.Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.Atomic modeling of cryo-electron microscopy reconstructions--joint refinement of model and imaging parameters.Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?Characterization of naturally-occurring humoral immunity to AAV in sheep.The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9 Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes.Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants AAV ancestral reconstruction library enables selection of broadly infectious viral variants.

P2860

Q27647639-DF05A336-9B37-401D-8A01-81568E71812D Q27661320-1E6AFA10-D613-495D-9D45-1570719D7068 Q27664641-CD7C943D-DCFD-4A30-9A9A-67647E28557C Q27673394-73A1AE53-47E0-4B7E-9724-1FD0C15B21EE Q27673885-FBC4A83F-4F0F-4A5B-A741-A00608E04DD2 Q27678476-2C1D3766-6366-4E59-BDB4-A721C26F04E0 Q27679454-C75ECE3A-741F-4CBE-8F6B-41882C80E572 Q27681034-2FED7D23-18E9-43A6-A239-164FACB3014D Q27681347-60E7AC33-88F3-492F-B636-D295CB84A203 Q27682946-762403C7-6CBC-4A1C-91A5-9833A15A62CD Q28083324-EE0A350B-6A23-4ADA-A07C-8A04E3E5A6B1 Q30152836-6DFA67C6-59EA-4B01-B1A6-A5B1F6D8A408 Q30152887-2C23A6EE-3F6B-4CDD-956D-7BA183C70741 Q30490945-0AC1836D-57DF-410F-B279-C1E3914A0003 Q30557598-1D559036-87F3-487E-A0A1-4F1A0D3AC788 Q33296224-535D1AC8-83C0-43AF-B56C-05825987D0E6 Q33327474-2CB48406-62DB-427A-B3B1-BEB9AD88D663 Q33337378-C40E4B6A-1D31-4396-94CA-4783217A4617 Q33353795-F47141D4-EBFC-433E-AB18-BC12B08DE4EB Q33363531-D1CAFA76-8C9B-4EF3-BBAF-11BE18E80FA7 Q33492733-862A739A-CC39-49EB-80EB-DFE1EEA76F4D Q33555259-60CCBFA2-A9FF-4E9E-8991-4CBA6048A59F Q33633258-3F30D2E5-9AA7-4D3F-AC51-98EB87D917A8 Q33833473-802881B2-9C0F-452B-B6CD-ABED6B404A7B Q33908400-12A13038-FBD0-42B6-8CEE-26AF68AA1BE0 Q33995646-4DDA82D1-33CD-4671-8998-C0B166815CFC Q34034500-7E0B6F7A-B26E-408C-A423-D1E93227748B Q34069571-8E3CB611-6E92-4AE4-B310-73EDB2AC48F0 Q34132611-1FD1F8E6-8A6F-49D1-9945-86D4FBCB7BBE Q34342494-66852D7A-DD98-45C8-BABB-F932DB4E36FD Q34370111-E3A26654-7789-4771-BD32-B1969CC09B6E Q34572922-F5BA816B-1C87-4699-9941-7153D0BC76FA Q34633598-5CA43F4B-50CD-459E-8715-6A44AD8577FF Q34634722-00AEA32A-95E3-4444-AE12-467DC0E71D4A Q35005408-7453F5A7-BB6B-42A0-B2C2-05CABBAA3E31 Q35101411-691A1DB7-01D1-4F7F-86FC-97E08E69F92F Q35139648-236F3C69-CACC-4A15-AF31-554C9E66F65B Q35140088-C86C5DF7-2397-4B23-A6B4-C5302AC5289F Q35210473-707D1A6E-8DBC-49C9-9061-AD227EAE90DD Q35695082-ADBCF6AD-A34E-4C74-A6C7-5604B0549E9E

P2860

Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.

http://www.wikidata.org/entity/Q42203239

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Mutations on the external surf ...... ansduction and neutralization.

@en

Mutations on the external surf ...... ansduction and neutralization.

@nl

type

label

Mutations on the external surf ...... ansduction and neutralization.

@en

Mutations on the external surf ...... ansduction and neutralization.

@nl

prefLabel

Mutations on the external surf ...... ansduction and neutralization.

@en

Mutations on the external surf ...... ansduction and neutralization.

@nl

P1433

Q42203239-2678F233-80E1-4C4C-86C5-688DCC6FFBC8

P1476

Q42203239-167AC5C1-2A65-450F-9383-DB0C42F024D4

P2093

Q42203239-293FEA24-D60E-4BAC-9D08-2F50B33235E0

Q42203239-2E38ACF9-1660-43ED-8851-8480E5BB9C25

Q42203239-809301A8-1C68-4976-BC7A-8027DC22AD5F

Q42203239-AEC9CE82-0532-49E9-8FB0-5F2A3BFB6C4C

Q42203239-B136C260-11E0-44EA-90C1-70FF5C4D876C

Q42203239-CD42BF33-EBB0-4926-8C6B-C31C5BD3100D

Q42203239-ED7D69C8-6272-4B6B-B7EB-B00E6986BE9A

Q42203239-F7ACAB44-FE92-4E47-89AB-979C04F43842

P2860

Q42203239-0094F87F-571D-4C64-8A01-92728BDD6703

Q42203239-026F70D7-24F9-4CC1-9937-94B3A7CCD109

Q42203239-06DEEC59-12FF-4673-8AC3-784F2F290AFA

Q42203239-0EBFDA1A-F59F-41A0-88BD-B20D56A91D24

Q42203239-107900BA-2513-473D-8328-6C44C20DE64B

Q42203239-18177862-AA74-4D38-B702-56E39ECBF0B1

Q42203239-186BEFAC-CAE6-4551-8759-F4A50C78EB05

Q42203239-195DD7F5-6E6B-484E-A0FA-4FBF52CAB0D3

Q42203239-1EE058E9-8C01-4FF2-AA94-876EEC3E3C7B

Q42203239-1FCD45F3-176E-4178-8634-649F81BC89AD

P304

Q42203239-627975CB-DBB6-4E80-9CD5-F43C61CA96D5

P31

Q42203239-03F243CA-EA00-43AF-8A8F-EF31F5A2EA74

P356

Q42203239-92412946-AFB4-44B1-BF0B-877C7D9F0702

P407

Q42203239-E15FD0F8-2F46-4E19-8853-A53CAD65FB6F

P433

Q42203239-C44085F4-E43E-42EC-BDAF-E7649C5A9227

P478

Q42203239-7310B397-6F70-4A5D-9DCA-2B6EEC1E003D

P577

Q42203239-DB41993A-C212-4EBC-B40D-6269D9476B6B

P698

Q42203239-016EE36E-1C03-4514-9370-8CAC211D33AC

P932

Q42203239-78A2A1D5-D608-4E3C-9C51-A60068DA6B8B

P356

JVI.80.2.821-834.2006

P1433

Journal of Virology

P1476

Mutations on the external surf ...... ansduction and neutralization.

@en

P2093

Brian Christie

http://www.w3.org/2001/XMLSchema#string

Glenn F Pierce

http://www.w3.org/2001/XMLSchema#string

Gwen P Tatsuno

http://www.w3.org/2001/XMLSchema#string

Jennifer Wellman McDonnell

http://www.w3.org/2001/XMLSchema#string

Michael A Lochrie

http://www.w3.org/2001/XMLSchema#string

Peter Colosi

http://www.w3.org/2001/XMLSchema#string

Richard Surosky

http://www.w3.org/2001/XMLSchema#string

Shangzhen Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.

Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors.

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display.

P304

821-834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.80.2.821-834.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16378984

http://www.w3.org/2001/XMLSchema#string

P932

1346838

http://www.w3.org/2001/XMLSchema#string